Argentinian mammarenavirus
| Amantadine | JUNV | Viroporin inhibitor; blocks viral ion channel activity | Approved (other) | Japan | Viral ion channel (viroporin) | |
| Amiloride | JUNV | Epithelial sodium channel inhibitor | Preclinical | — | Human ion channel | |
| Brequinar | JUNV | DHODH (DHODH) inhibitor | Preclinical | — | Human DHODH | |
| Caffeine | JUNV | Adenosine-receptor antagonist | Preclinical | — | Viral RNA pol | |
| Leflunomide | JUNV | Pyrimidine synthesis inhibitor | Preclinical | — | Human DHODH | |
| Merimepodib | JUNV | IMPDH inhibitor | Preclinical | — | Human IMPDH | |
| Mycophenolic acid | JUNV | Inosine monophosphate dehydrogenase inhibitor | Preclinical | — | Human IMPDH | |
| Obatoclax | JUNV | Bcl-2 family inhibitor | Preclinical | — | Human MCL1 | |
| Remdesivir | JUNV | Viral RNA polymerase inhibitor | Approved (other) | Japan | Viral RNA pol | |
| Sunitinib | JUNV | Broad TK inhibitor | Preclinical | — | Human PTK | |
| Umifenovir | JUNV | Inhibits membrane fusion | Preclinical | — | Human (multiple) |